Complications following infusion, transfusion and therapeutic injection (T80)

Browse all the diagnosis codes used for complications following infusion, transfusion and therapeutic injection (t80). For easy navigation, the diagnosis codes are sorted in alphabetical order and grouped by sections. Each section is clearly marked with its description, and the corresponding three-digit code range. This format makes it simple to browse diagnosis codes in this chapter or section and find what you're looking for. We've also added green checkmark icons to label billable codes, and red warning icons for non-billable ones. This makes it easy to identify which codes can be billed.

Clinical Information

Blood Transfusion - The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed)

Cytokine Release Syndrome - A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.

Hemosiderosis - Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the MONONUCLEAR PHAGOCYTE SYSTEM, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin.

Hydrothorax - A collection of watery fluid in the pleural cavity. (Dorland, 27th ed)

Mononuclear Phagocyte System - Mononuclear cells with pronounced phagocytic ability that are distributed extensively in lymphoid and other organs. It includes MACROPHAGES and their precursors; PHAGOCYTES; KUPFFER CELLS; HISTIOCYTES; DENDRITIC CELLS; LANGERHANS CELLS; and MICROGLIA. The term mononuclear phagocyte system has replaced the former reticuloendothelial system, which also included less active phagocytic cells such as fibroblasts and endothelial cells. (From Illustrated Dictionary of Immunology, 2d ed.)

Transfusion Reaction - Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.

Instructional Notations

Includes

This note appears immediately under a three character code title to further define, or give examples of, the content of the category.

  • complications following perfusion

Type 2 Excludes

A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.

  • bone marrow transplant rejection T86.01
  • febrile nonhemolytic transfusion reaction R50.84
  • fluid overload due to transfusion E87.71
  • posttransfusion purpura D69.51
  • transfusion associated circulatory overload TACO E87.71
  • transfusion red blood cell associated hemochromatosis E83.111
  • transfusion related acute lung injury TRALI J95.84

7th Character Note

Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.

  • The appropriate 7th character is to be added to each code from category T80

7th Character

Indicates that a seventh character is to be assigned to codes in a subcategory.

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela
  • Injury, poisoning and certain other consequences of external causes (S00–T88)

    • Complications of surgical and medical care, not elsewhere classified (T80-T88)

        • Complications following infusion, transfusion and therapeutic injection (T80)

        • T80 Complications following infusion, transfusion and therapeutic injection
        • T80.0 Air embolism following infusion, transfusion and therapeutic injection
        • T80.0XXA Air embolism following infusion, transfusion and therapeutic injection, initial encounter
        • T80.0XXD Air embolism following infusion, transfusion and therapeutic injection, subsequent encounter
        • T80.0XXS Air embolism following infusion, transfusion and therapeutic injection, sequela
        • T80.1 Vascular complications following infusion, transfusion and therapeutic injection
        • T80.1XXA Vascular complications following infusion, transfusion and therapeutic injection, initial encounter
        • T80.1XXD Vascular complications following infusion, transfusion and therapeutic injection, subsequent encounter
        • T80.1XXS Vascular complications following infusion, transfusion and therapeutic injection, sequela
        • T80.2 Infections following infusion, transfusion and therapeutic injection
        • T80.21 Infection due to central venous catheter
        • T80.211 Bloodstream infection due to central venous catheter
        • T80.211A Bloodstream infection due to central venous catheter, initial encounter
        • T80.211D Bloodstream infection due to central venous catheter, subsequent encounter
        • T80.211S Bloodstream infection due to central venous catheter, sequela
        • T80.212 Local infection due to central venous catheter
        • T80.212A Local infection due to central venous catheter, initial encounter
        • T80.212D Local infection due to central venous catheter, subsequent encounter
        • T80.212S Local infection due to central venous catheter, sequela
        • T80.218 Other infection due to central venous catheter
        • T80.218A Other infection due to central venous catheter, initial encounter
        • T80.218D Other infection due to central venous catheter, subsequent encounter
        • T80.218S Other infection due to central venous catheter, sequela
        • T80.219 Unspecified infection due to central venous catheter
        • T80.219A Unspecified infection due to central venous catheter, initial encounter
        • T80.219D Unspecified infection due to central venous catheter, subsequent encounter
        • T80.219S Unspecified infection due to central venous catheter, sequela
        • T80.22 Acute infection following transfusion, infusion, or injection of blood and blood products
        • T80.22XA Acute infection following transfusion, infusion, or injection of blood and blood products, initial encounter
        • T80.22XD Acute infection following transfusion, infusion, or injection of blood and blood products, subsequent encounter
        • T80.22XS Acute infection following transfusion, infusion, or injection of blood and blood products, sequela
        • T80.29 Infection following other infusion, transfusion and therapeutic injection
        • T80.29XA Infection following other infusion, transfusion and therapeutic injection, initial encounter
        • T80.29XD Infection following other infusion, transfusion and therapeutic injection, subsequent encounter
        • T80.29XS Infection following other infusion, transfusion and therapeutic injection, sequela
        • T80.3 ABO incompatibility reaction due to transfusion of blood or blood products
        • T80.30 ABO incompatibility reaction due to transfusion of blood or blood products, unspecified
        • T80.30XA ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter
        • T80.30XD ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, subsequent encounter
        • T80.30XS ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, sequela
        • T80.31 ABO incompatibility with hemolytic transfusion reaction
        • T80.310 ABO incompatibility with acute hemolytic transfusion reaction
        • T80.310A ABO incompatibility with acute hemolytic transfusion reaction, initial encounter
        • T80.310D ABO incompatibility with acute hemolytic transfusion reaction, subsequent encounter
        • T80.310S ABO incompatibility with acute hemolytic transfusion reaction, sequela
        • T80.311 ABO incompatibility with delayed hemolytic transfusion reaction
        • T80.311A ABO incompatibility with delayed hemolytic transfusion reaction, initial encounter
        • T80.311D ABO incompatibility with delayed hemolytic transfusion reaction, subsequent encounter
        • T80.311S ABO incompatibility with delayed hemolytic transfusion reaction, sequela
        • T80.319 ABO incompatibility with hemolytic transfusion reaction, unspecified
        • T80.319A ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter
        • T80.319D ABO incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter
        • T80.319S ABO incompatibility with hemolytic transfusion reaction, unspecified, sequela
        • T80.39 Other ABO incompatibility reaction due to transfusion of blood or blood products
        • T80.39XA Other ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter
        • T80.39XD Other ABO incompatibility reaction due to transfusion of blood or blood products, subsequent encounter
        • T80.39XS Other ABO incompatibility reaction due to transfusion of blood or blood products, sequela
        • T80.4 Rh incompatibility reaction due to transfusion of blood or blood products
        • T80.40 Rh incompatibility reaction due to transfusion of blood or blood products, unspecified
        • T80.40XA Rh incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter
        • T80.40XD Rh incompatibility reaction due to transfusion of blood or blood products, unspecified, subsequent encounter
        • T80.40XS Rh incompatibility reaction due to transfusion of blood or blood products, unspecified, sequela
        • T80.41 Rh incompatibility with hemolytic transfusion reaction
        • T80.410 Rh incompatibility with acute hemolytic transfusion reaction
        • T80.410A Rh incompatibility with acute hemolytic transfusion reaction, initial encounter
        • T80.410D Rh incompatibility with acute hemolytic transfusion reaction, subsequent encounter
        • T80.410S Rh incompatibility with acute hemolytic transfusion reaction, sequela
        • T80.411 Rh incompatibility with delayed hemolytic transfusion reaction
        • T80.411A Rh incompatibility with delayed hemolytic transfusion reaction, initial encounter
        • T80.411D Rh incompatibility with delayed hemolytic transfusion reaction, subsequent encounter
        • T80.411S Rh incompatibility with delayed hemolytic transfusion reaction, sequela
        • T80.419 Rh incompatibility with hemolytic transfusion reaction, unspecified
        • T80.419A Rh incompatibility with hemolytic transfusion reaction, unspecified, initial encounter
        • T80.419D Rh incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter
        • T80.419S Rh incompatibility with hemolytic transfusion reaction, unspecified, sequela
        • T80.49 Other Rh incompatibility reaction due to transfusion of blood or blood products
        • T80.49XA Other Rh incompatibility reaction due to transfusion of blood or blood products, initial encounter
        • T80.49XD Other Rh incompatibility reaction due to transfusion of blood or blood products, subsequent encounter
        • T80.49XS Other Rh incompatibility reaction due to transfusion of blood or blood products, sequela
        • T80.5 Anaphylactic reaction due to serum
        • T80.51 Anaphylactic reaction due to administration of blood and blood products
        • T80.51XA Anaphylactic reaction due to administration of blood and blood products, initial encounter
        • T80.51XD Anaphylactic reaction due to administration of blood and blood products, subsequent encounter
        • T80.51XS Anaphylactic reaction due to administration of blood and blood products, sequela
        • T80.52 Anaphylactic reaction due to vaccination
        • T80.52XA Anaphylactic reaction due to vaccination, initial encounter
        • T80.52XD Anaphylactic reaction due to vaccination, subsequent encounter
        • T80.52XS Anaphylactic reaction due to vaccination, sequela
        • T80.59 Anaphylactic reaction due to other serum
        • T80.59XA Anaphylactic reaction due to other serum, initial encounter
        • T80.59XD Anaphylactic reaction due to other serum, subsequent encounter
        • T80.59XS Anaphylactic reaction due to other serum, sequela
        • T80.6 Other serum reactions
        • T80.61 Other serum reaction due to administration of blood and blood products
        • T80.61XA Other serum reaction due to administration of blood and blood products, initial encounter
        • T80.61XD Other serum reaction due to administration of blood and blood products, subsequent encounter
        • T80.61XS Other serum reaction due to administration of blood and blood products, sequela
        • T80.62 Other serum reaction due to vaccination
        • T80.62XA Other serum reaction due to vaccination, initial encounter
        • T80.62XD Other serum reaction due to vaccination, subsequent encounter
        • T80.62XS Other serum reaction due to vaccination, sequela
        • T80.69 Other serum reaction due to other serum
        • T80.69XA Other serum reaction due to other serum, initial encounter
        • T80.69XD Other serum reaction due to other serum, subsequent encounter
        • T80.69XS Other serum reaction due to other serum, sequela
        • T80.8 Other complications following infusion, transfusion and therapeutic injection
        • T80.81 Extravasation of vesicant agent
        • T80.810 Extravasation of vesicant antineoplastic chemotherapy
        • T80.810A Extravasation of vesicant antineoplastic chemotherapy, initial encounter
        • T80.810D Extravasation of vesicant antineoplastic chemotherapy, subsequent encounter
        • T80.810S Extravasation of vesicant antineoplastic chemotherapy, sequela
        • T80.818 Extravasation of other vesicant agent
        • T80.818A Extravasation of other vesicant agent, initial encounter
        • T80.818D Extravasation of other vesicant agent, subsequent encounter
        • T80.818S Extravasation of other vesicant agent, sequela
        • T80.82 Complication of immune effector cellular therapy
        • T80.82XA Complication of immune effector cellular therapy, initial encounter
        • T80.82XD Complication of immune effector cellular therapy, subsequent encounter
        • T80.82XS Complication of immune effector cellular therapy, sequela
        • T80.89 Other complications following infusion, transfusion and therapeutic injection
        • T80.89XA Other complications following infusion, transfusion and therapeutic injection, initial encounter
        • T80.89XD Other complications following infusion, transfusion and therapeutic injection, subsequent encounter
        • T80.89XS Other complications following infusion, transfusion and therapeutic injection, sequela
        • T80.9 Unspecified complication following infusion, transfusion and therapeutic injection
        • T80.90 Unspecified complication following infusion and therapeutic injection
        • T80.90XA Unspecified complication following infusion and therapeutic injection, initial encounter
        • T80.90XD Unspecified complication following infusion and therapeutic injection, subsequent encounter
        • T80.90XS Unspecified complication following infusion and therapeutic injection, sequela
        • T80.91 Hemolytic transfusion reaction, unspecified incompatibility
        • T80.910 Acute hemolytic transfusion reaction, unspecified incompatibility
        • T80.910A Acute hemolytic transfusion reaction, unspecified incompatibility, initial encounter
        • T80.910D Acute hemolytic transfusion reaction, unspecified incompatibility, subsequent encounter
        • T80.910S Acute hemolytic transfusion reaction, unspecified incompatibility, sequela
        • T80.911 Delayed hemolytic transfusion reaction, unspecified incompatibility
        • T80.911A Delayed hemolytic transfusion reaction, unspecified incompatibility, initial encounter
        • T80.911D Delayed hemolytic transfusion reaction, unspecified incompatibility, subsequent encounter
        • T80.911S Delayed hemolytic transfusion reaction, unspecified incompatibility, sequela
        • T80.919 Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed
        • T80.919A Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed, initial encounter
        • T80.919D Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed, subsequent encounter
        • T80.919S Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed, sequela
        • T80.92 Unspecified transfusion reaction
        • T80.92XA Unspecified transfusion reaction, initial encounter
        • T80.92XD Unspecified transfusion reaction, subsequent encounter
        • T80.92XS Unspecified transfusion reaction, sequela
        • T80.A Non-ABO incompatibility reaction due to transfusion of blood or blood products
        • T80.A0 Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified
        • T80.A0XA Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter
        • T80.A0XD Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, subsequent encounter
        • T80.A0XS Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, sequela
        • T80.A1 Non-ABO incompatibility with hemolytic transfusion reaction
        • T80.A10 Non-ABO incompatibility with acute hemolytic transfusion reaction
        • T80.A10A Non-ABO incompatibility with acute hemolytic transfusion reaction, initial encounter
        • T80.A10D Non-ABO incompatibility with acute hemolytic transfusion reaction, subsequent encounter
        • T80.A10S Non-ABO incompatibility with acute hemolytic transfusion reaction, sequela
        • T80.A11 Non-ABO incompatibility with delayed hemolytic transfusion reaction
        • T80.A11A Non-ABO incompatibility with delayed hemolytic transfusion reaction, initial encounter
        • T80.A11D Non-ABO incompatibility with delayed hemolytic transfusion reaction, subsequent encounter
        • T80.A11S Non-ABO incompatibility with delayed hemolytic transfusion reaction, sequela
        • T80.A19 Non-ABO incompatibility with hemolytic transfusion reaction, unspecified
        • T80.A19A Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter
        • T80.A19D Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter
        • T80.A19S Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, sequela
        • T80.A9 Other non-ABO incompatibility reaction due to transfusion of blood or blood products
        • T80.A9XA Other non-ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter
        • T80.A9XD Other non-ABO incompatibility reaction due to transfusion of blood or blood products, subsequent encounter
        • T80.A9XS Other non-ABO incompatibility reaction due to transfusion of blood or blood products, sequela